Orlando, FL June 7, 2023- Seal Shield, a leader in infection control and disinfection solutions, announces the acquisition of CleanSlate UV, a leading provider of UV-C and device sanitization solutions. This strategic move cements Seal Shield’s position as the industry leader in device sanitization, combining Seal Shield’s suite of healthcare hygiene products with CleanSlate UV’s patented UV-C technologies.
The acquisition of CleanSlate UV’s suite of UV-C sanitization solutions will strategically enhance Seal Shield’s UV-C division. Seal Shield’s ElectroClave™ UV-C LED solution is the gold standard for healthcare enterprise device sanitization, enabling the frequent cleaning of those devices with no material degradation. The ElectroClave™ perfectly complements the CleanSlate™ sanitizer, renowned for its wide range of applications and rapid sanitization of devices at hand washing stations and in point-of-care environments. The ElectroClave™ and CleanSlate™ sanitizers are 99.9% effective against Staphylococcus, Escherichia coli, MRSA and CRE on hard, non-porous surfaces. Together, these products provide a comprehensive and superior device sanitization offering which ensures the effective sanitization of hard, non-porous surfaces.
The acquisition of CleanSlate UV solidifies Seal Shield’s commitment to driving positive change in infection control practices. With their expanded capabilities and resources, Seal Shield is poised to set new industry standards, ensuring safer and healthier environments across healthcare and other sectors.
About Seal Shield: Seal Shield, a pioneer in healthcare infection control solutions, specializes in creating innovative products that promote health and wellness. With a relentless commitment to excellence, Seal Shield develops cutting-edge technologies and solutions that set infection control industry standards and provide improved healthcare outcomes.
Media Contact: Alyssa Jappy, Marketing Manager, alyssa.jappy@sealshield.com 877-325-7443
